Long-term evaluation of NEDA-3 status in relapsing-remitting multiple sclerosis patients after switching from natalizumab to fingolimod

Therapeutic Advances in Neurological Disorders ◽

10.1177/1756286418791103 ◽

2018 ◽

Vol 11 ◽

pp. 175628641879110 ◽

Author(s):

Lara Diem ◽

Krassen Nedeltchev ◽

Timo Kahles ◽

Lutz Achtnichts ◽

Oliver Findling

Keyword(s):

Multiple Sclerosis ◽

Relapsing Remitting ◽

Term Evaluation ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Effectiveness and Safety of Long-Term Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients with Highly Active Disease

10.26226/morressier.59a3e8b6d462b8028d8953f4 ◽

2017 ◽

Author(s):

Galina Vorobeychik

Keyword(s):

Multiple Sclerosis ◽

Highly Active ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis ◽

Download Full-text

Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab

Multiple Sclerosis and Related Disorders ◽

10.1016/j.msard.2019.05.017 ◽

2019 ◽

Vol 33 ◽

pp. 82-87 ◽

Author(s):

I. Dekker ◽

C.E. Leurs ◽

M.H.J. Hagens ◽

Z.L.E. van Kempen ◽

I. Kleerekooper ◽

...

Keyword(s):

Multiple Sclerosis ◽

Disease Activity ◽

Disability Progression ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Early disturbances in multimodal evoked potentials as a prognostic factor for long-term disability in relapsing-remitting multiple sclerosis patients

Clinical Neurophysiology ◽

10.1016/j.clinph.2016.12.029 ◽

2017 ◽

Vol 128 (4) ◽

pp. 561-569 ◽

Author(s):

Frédéric London ◽

Souraya El Sankari ◽

Vincent van Pesch

Keyword(s):

Multiple Sclerosis ◽

Prognostic Factor ◽

Evoked Potentials ◽

Relapsing Remitting ◽

Multimodal Evoked Potentials ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Correction to: Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients

Journal of Neurology ◽

10.1007/s00415-021-10906-x ◽

2021 ◽

Author(s):

Jordi Río ◽

Àlex Rovira ◽

Claudio Gasperini ◽

Mar Tintoré ◽

Luca Prosperini ◽

...

Keyword(s):

Multiple Sclerosis ◽

Treatment Response ◽

Scoring Systems ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Long Term Prognosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients

Journal of Neurology ◽

10.1007/s00415-021-10823-z ◽

2021 ◽

Author(s):

Jordi Río ◽

Àlex Rovira ◽

Claudio Gasperini ◽

Mar Tintoré ◽

Luca Prosperini ◽

...

Keyword(s):

Multiple Sclerosis ◽

Treatment Response ◽

Scoring Systems ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Long Term Prognosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Real-world data from over 10 years in the TYSABRI® Observational Program: Long-term safety and effectiveness of natalizumab in relapsing-remitting multiple sclerosis patients

Revue Neurologique ◽

10.1016/j.neurol.2019.01.271 ◽

2019 ◽

Vol 175 ◽

pp. S101-S102 ◽

Author(s):

Ludwig Kappos ◽

Helmut Butzkueven ◽

Tim Spelman ◽

Maria Trojano ◽

Heinz Wiendl ◽

...

Keyword(s):

Multiple Sclerosis ◽

Real World Data ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis ◽

Observational Program

Download Full-text

JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients

10.26226/morressier.59a3e8b6d462b8028d89506e ◽

2017 ◽

Author(s):

Pabitra Basnyat

Keyword(s):

Multiple Sclerosis ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients

Journal of NeuroVirology ◽

10.1007/s13365-017-0560-x ◽

2017 ◽

Vol 23 (5) ◽

pp. 734-741 ◽

Author(s):

Pabitra Basnyat ◽

Elina Virtanen ◽

Irina Elovaara ◽

Sanna Hagman ◽

Eeva Auvinen

Keyword(s):

Multiple Sclerosis ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Long-Term Stability of Neuroaxonal Structure in Alemtuzumab-Treated Relapsing–Remitting Multiple Sclerosis Patients

Journal of Neuro-Ophthalmology ◽

10.1097/wno.0000000000000802 ◽

2020 ◽

Vol 40 (1) ◽

pp. 37-43

Author(s):

Jillian K. Chan ◽

Elena Hernandez Martínez de Lapiscina ◽

Carolyn Taylor ◽

Ai-Lan Nguyen ◽

Salut Alba-Arbalat ◽

...

Keyword(s):

Multiple Sclerosis ◽

Term Stability ◽

Long Term Stability ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Early disturbances in multimodal evoked potentials as a prognostic factor for long-term disability in relapsing-remitting multiple sclerosis patients

Revue Neurologique ◽

10.1016/j.neurol.2018.02.015 ◽

2018 ◽

Vol 174 ◽

pp. S164

Author(s):

F. London ◽

S. El Sankari ◽

V. Van Pesch

Keyword(s):

Multiple Sclerosis ◽

Prognostic Factor ◽

Evoked Potentials ◽

Relapsing Remitting ◽

Multimodal Evoked Potentials ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text